KRAS c.116C>G ;(p.S39C)

Variant ID: 12-25380342-G-C

NM_004985.3(KRAS):c.116C>G;(p.S39C)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


In Silico Evaluation of the Thr58-Associated Conserved Water with KRAS Switch-II Pocket Binders.

Journal Of Chemical Information And Modeling
Leini, Renne R; Pantsar, Tatu T
Publication Date: 2023-02-28

Variant appearance in text: KRAS: S39C
PubMed Link: 36854010
Variant Present in the following documents:
  • Main text
  • ci2c01479.pdf
View BVdb publication page



Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor.

Journal Of Medicinal Chemistry
Bröker, Joachim J; Waterson, Alex G AG; Smethurst, Chris C; Kessler, Dirk D; Böttcher, Jark J; Mayer, Moriz M; Gmaschitz, Gerhard G; Phan, Jason J; Little, Andrew A; Abbott, Jason R JR; Sun, Qi Q; Gmachl, Michael M; Rudolph, Dorothea D; Arnhof, Heribert H; Rumpel, Klaus K; Savarese, Fabio F; Gerstberger, Thomas T; Mischerikow, Nikolai N; Treu, Matthias M; Herdeis, Lorenz L; Wunberg, Tobias T; Gollner, Andreas A; Weinstabl, Harald H; Mantoulidis, Andreas A; Krämer, Oliver O; McConnell, Darryl B DB; W Fesik, Stephen S
Publication Date: 2022-11-10

Variant appearance in text: KRAS: S39C
PubMed Link: 36300829
Variant Present in the following documents:
  • Main text
  • jm2c01120.pdf
  • jm2c01120_si_001.pdf
View BVdb publication page



Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine-dependent interface: a model for KRAS oligomerization.

Chemical Science
Lee, Ki-Young KY; Enomoto, Masahiro M; Gebregiworgis, Teklab T; Gasmi-Seabrook, Geneviève M C GMC; Ikura, Mitsuhiko M; Marshall, Christopher B CB
Publication Date: 2021-10-06

Variant appearance in text: KRAS: S39C
PubMed Link: 34703570
Variant Present in the following documents:
  • SC-012-D1SC03484G-s001.pdf
View BVdb publication page